These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 14630739)

  • 41. Risks and benefits of using antiretroviral therapy in HIV-infected patients with chronic hepatitis B in developing regions.
    Soriano V; Rivas P; Nuñez M
    Clin Infect Dis; 2008 Dec; 47(11):1486-9. PubMed ID: 18937578
    [No Abstract]   [Full Text] [Related]  

  • 42. Abacavir, Didanosine: myocardial infarction.
    Prescrire Int; 2008 Dec; 17(98):244. PubMed ID: 19431227
    [No Abstract]   [Full Text] [Related]  

  • 43. Timing of antiretroviral drugs during tuberculosis therapy.
    Garcia-Vidal C; Salvado M; Salavert M
    N Engl J Med; 2010 Jun; 362(22):2137-8; author reply 2138-9. PubMed ID: 20527080
    [No Abstract]   [Full Text] [Related]  

  • 44. [Interactions of cardiac and antiretroviral medication].
    Egger S; Drewe J
    Herz; 2005 Sep; 30(6):493-503. PubMed ID: 16170680
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early versus deferred antiretroviral therapy for HIV.
    Arribas JR; Mora M; Pascual-Pareja JF
    N Engl J Med; 2009 Aug; 361(8):823; author reply 823-4. PubMed ID: 19701985
    [No Abstract]   [Full Text] [Related]  

  • 46. Early increases in concentrations of total, LDL, and HDL cholesterol in HIV-infected children following new exposure to antiretroviral therapy.
    Sztam KA; Jiang H; Jurgrau A; Deckelbaum RJ; Foca MD
    J Pediatr Gastroenterol Nutr; 2011 Apr; 52(4):495-8. PubMed ID: 21206378
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Coronary heart disease associated with the use of highly active antiretroviral therapy (HAART). A case report and review].
    Neumann T; Kondratieva J; Eggebrecht H; Wieneke H; Esser S; Bartel T; Erbel R
    Herz; 2005 Sep; 30(6):504-9. PubMed ID: 16170681
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HIV infection and cardiovascular disease--is there really a link?
    Sklar P; Masur H
    N Engl J Med; 2003 Nov; 349(21):2065-7. PubMed ID: 14627792
    [No Abstract]   [Full Text] [Related]  

  • 49. Effects of HIV infection and antiretroviral therapy on the heart and vasculature.
    Dubé MP; Lipshultz SE; Fichtenbaum CJ; Greenberg R; Schecter AD; Fisher SD;
    Circulation; 2008 Jul; 118(2):e36-40. PubMed ID: 18566318
    [No Abstract]   [Full Text] [Related]  

  • 50. Summaries for patients. Efavirenz and the risk for suicidal behaviors.
    Ann Intern Med; 2014 Jul; 161(1):I-14. PubMed ID: 24979460
    [No Abstract]   [Full Text] [Related]  

  • 51. Leprosy after starting antiretroviral treatment.
    Lawn SD; Lockwood DN
    BMJ; 2007 Feb; 334(7587):217-8. PubMed ID: 17272530
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Incomplete Modeling of the Effect of Antiretroviral Therapy on the Risk of Cardiovascular Events.
    Young J; Moodie EE; Abrahamowicz M; Klein MB; Weber R; Bucher HC
    Clin Infect Dis; 2015 Oct; 61(7):1206-7. PubMed ID: 26123934
    [No Abstract]   [Full Text] [Related]  

  • 53. A comment on "Does first line antiretroviral therapy increase the prevalence of cardiovascular risk factors in Indian patients?: a cross sectional study".
    Raina SK
    J Postgrad Med; 2014; 60(2):226. PubMed ID: 24823544
    [No Abstract]   [Full Text] [Related]  

  • 54. Nephrotoxicity of antiretroviral agents: is the list getting longer?
    Fine DM; Gallant JE
    J Infect Dis; 2013 May; 207(9):1349-51. PubMed ID: 23382574
    [No Abstract]   [Full Text] [Related]  

  • 55. Free InterApp ARV: The subsequent version of SIMARV® to analyse the clinical relevance of drug interactions with antiretroviral agents in patients with HIV/AIDS.
    Amariles P; Giraldo N; Madrigal-Cadavid J; Granados J
    Res Social Adm Pharm; 2019 Nov; 15(11):1376. PubMed ID: 31353121
    [No Abstract]   [Full Text] [Related]  

  • 56. HIV infection and stroke: if not protein S deficiency then what explains the relationship?
    Qureshi AI
    J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1331. PubMed ID: 16170070
    [No Abstract]   [Full Text] [Related]  

  • 57. Reply to Young et al.
    Desai M; Joyce V; Bendavid E; Olshen RA; Hlatky M; Chow A; Holodniy M; Barnett P; Owens DK
    Clin Infect Dis; 2015 Oct; 61(7):1207-8. PubMed ID: 26123931
    [No Abstract]   [Full Text] [Related]  

  • 58. Leveraging Experience From Active TB Drug-Safety Monitoring and Management for Monitoring Active Antiretroviral Toxicity.
    Stevens L; Perry KE; Moide I; Kaemala F; Nankinga J; Innes AL; Mogaba I
    Glob Health Sci Pract; 2022 Apr; 10(2):. PubMed ID: 35487562
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multimorbidity in African ancestry populations: a scoping review.
    Kamp M; Achilonu O; Kisiangani I; Nderitu DM; Mpangase PT; Tadesse GA; Adetunji K; Iddi S; Speakman S; Hazelhurst S; Asiki G; Ramsay M;
    BMJ Glob Health; 2023 Dec; 8(12):. PubMed ID: 38084495
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antiretroviral therapy increases risk of heart attack.
    Gottlieb S
    BMJ; 2003 Nov; 327(7425):1186. PubMed ID: 14630739
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.